"Approval Date","Drug Name","Submission","Active Ingredients","Company","Submission Classification *","Submission Status"
"02/01/2022","MONOKETNDA   #020215","SUPPL-27","ISOSORBIDE MONONITRATE","ECI PHARMS LLC","Manufacturing (CMC)","Approval"
"02/01/2022","AFINITORNDA   #022334","SUPPL-51","EVEROLIMUS","NOVARTIS","Labeling","Approval"
"02/01/2022","NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINCANDA  #060764","SUPPL-19","BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE","PADAGIS US","Labeling","Approval"
"02/01/2022","JUXTAPIDNDA   #203858","SUPPL-23","LOMITAPIDE MESYLATE","AMRYT","REMS","Approval"
"02/01/2022","AFINITOR DISPERZNDA   #203985","SUPPL-23","EVEROLIMUS","NOVARTIS PHARM","Labeling","Approval"
"02/01/2022","RUZURGINDA   #209321","ORIG-1","AMIFAMPRIDINE","JACOBUS PHARM CO INC","Type 2 - New Active Ingredient","Tentative Approval"
"02/01/2022","RUZURGINDA   #209321","SUPPL-1","AMIFAMPRIDINE","JACOBUS PHARM CO INC","Labeling","Tentative Approval"
"02/01/2022","APIXABANANDA  #210053","ORIG-1","APIXABAN","SIGMAPHARM LABS LLC","","Tentative Approval"
"02/01/2022","GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDEANDA  #214407","ORIG-1","GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE","L PERRIGO CO","","Approval"
"02/02/2022","KADCYLABLA   #125427","SUPPL-111","ADO-TRASTUZUMAB EMTANSINE","GENENTECH","","Approval"
"02/02/2022","NORGESTIMATE AND ETHINYL ESTRADIOLANDA  #200383","SUPPL-1","ETHINYL ESTRADIOL; NORGESTIMATE","NAARI PTE LTD","Labeling","Approval"
"02/02/2022","NORGESTIMATE AND ETHINYL ESTRADIOLANDA  #200383","SUPPL-2","ETHINYL ESTRADIOL; NORGESTIMATE","NAARI PTE LTD","Labeling","Approval"
"02/02/2022","CYCLOSPORINEANDA  #205894","ORIG-1","CYCLOSPORINE","MYLAN PHARMS","","Approval"
"02/02/2022","EZETIMIBE AND SIMVASTATINANDA  #208699","SUPPL-2","EZETIMIBE; SIMVASTATIN","GLENMARK PHARMS LTD","Labeling","Approval"
"02/02/2022","COPIKTRANDA   #211155","SUPPL-6","DUVELISIB","SECURA","REMS","Approval"
"02/02/2022","ACETAMINOPHEN, ASPIRIN AND CAFFEINEANDA  #211695","ORIG-1","ACETAMINOPHEN; ASPIRIN; CAFFEINE","AUROBINDO PHARMA LTD","","Approval"
"02/02/2022","CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #211925","ORIG-1","AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE","MICRO LABS","","Approval"
"02/02/2022","ATAZANAVIR SULFATEANDA  #212278","ORIG-1","ATAZANAVIR SULFATE","HETERO LABS LTD III","","Approval"
"02/02/2022","GAVRETONDA   #213721","SUPPL-5","PRALSETINIB","GENENTECH INC","Labeling","Approval"
"02/02/2022","BUPROPION HYDROCHLORIDEANDA  #215568","ORIG-1","BUPROPION HYDROCHLORIDE","GRANULES","","Approval"
"02/03/2022","PREVIFEMANDA  #076334","SUPPL-23","ETHINYL ESTRADIOL; NORGESTIMATE","VINTAGE PHARMS LLC","Labeling","Approval"
"02/03/2022","TRI-PREVIFEMANDA  #076335","SUPPL-20","ETHINYL ESTRADIOL; NORGESTIMATE","VINTAGE PHARMS LLC","Labeling","Approval"
"02/03/2022","NORGESTIMATE AND ETHINYL ESTRADIOLANDA  #090479","SUPPL-1","ETHINYL ESTRADIOL; NORGESTIMATE","WATSON LABS","Labeling","Approval"
"02/03/2022","NORGESTIMATE; ETHINYL ESTRADIOLANDA  #090479","SUPPL-1","NORGESTIMATE; ETHINYL ESTRADIOL","WATSON LABS","Labeling","Approval"
"02/03/2022","MONO-LINYAHANDA  #090523","SUPPL-3","ETHINYL ESTRADIOL; NORGESTIMATE","NOVAST LABS LTD","Labeling","Approval"
"02/03/2022","TRI-LINYAHANDA  #090524","SUPPL-2","ETHINYL ESTRADIOL; NORGESTIMATE","NOVAST LABS LTD","Labeling","Approval"
"02/03/2022","TRI-ESTARYLLAANDA  #090793","SUPPL-6","ETHINYL ESTRADIOL; NORGESTIMATE","XIROMED","Labeling","Approval"
"02/03/2022","ESTARYLLAANDA  #090794","SUPPL-6","ETHINYL ESTRADIOL; NORGESTIMATE","XIROMED","Labeling","Approval"
"02/03/2022","TROKENDI XRNDA   #201635","SUPPL-29","TOPIRAMATE","SUPERNUS PHARMS","Labeling","Approval"
"02/03/2022","XIGDUO XRNDA   #205649","SUPPL-16","DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE","ASTRAZENECA AB","Efficacy","Approval"
"02/03/2022","MIGLUSTATANDA  #209325","ORIG-1","MIGLUSTAT","BRECKENRIDGE","","Approval"
"02/03/2022","AZACITIDINEANDA  #211549","ORIG-1","AZACITIDINE","AMNEAL","","Approval"
"02/03/2022","APREMILASTANDA  #211859","ORIG-1","APREMILAST","ZYDUS PHARMS","","Tentative Approval"
"02/03/2022","PRAMIPEXOLE DIHYDROCHLORIDEANDA  #213444","ORIG-1","PRAMIPEXOLE DIHYDROCHLORIDE","NOVAST LABS","","Approval"
"02/03/2022","ACETYLCYSTEINEANDA  #213693","ORIG-1","ACETYLCYSTEINE","ASPEN","","Approval"
"02/03/2022","ALKINDI SPRINKLENDA   #213876","SUPPL-1","HYDROCORTISONE","ETON","Labeling","Approval"
"02/03/2022","LAMOTRIGINEANDA  #214124","ORIG-1","LAMOTRIGINE","AMRING PHARMS","","Approval"
"02/03/2022","LINAGLIPTIN; METFORMIN HYDROCHLORIDEANDA  #214822","ORIG-1","LINAGLIPTIN;METFORMIN HYDROCHLORIDE","MSN LABORATORIES PRIVATE LTD","","Tentative Approval"
"02/03/2022","COLCHICINEANDA  #215463","ORIG-1","COLCHICINE","AUROBINDO PHARMA USA","","Tentative Approval"
"02/04/2022","CELEXANDA   #020822","SUPPL-41","CITALOPRAM HYDROBROMIDE","ABBVIE","Labeling","Approval"
"02/04/2022","KEYTRUDABLA   #125514","SUPPL-95","PEMBROLIZUMAB","MERCK SHARP DOHME","","Approval"
"02/04/2022","KEYTRUDABLA   #125514","SUPPL-125","PEMBROLIZUMAB","MERCK SHARP DOHME","","Approval"
"02/04/2022","TAFINLARNDA   #202806","SUPPL-21","DABRAFENIB MESYLATE","NOVARTIS","Manufacturing (CMC)","Approval"
"02/04/2022","INJECTAFERNDA   #203565","SUPPL-19","FERRIC CARBOXYMALTOSE","AM REGENT","Manufacturing (CMC)","Approval"
"02/04/2022","NORGESTIMATE AND ETHINYL ESTRADIOLANDA  #204057","SUPPL-1","ETHINYL ESTRADIOL; NORGESTIMATE","GLENMARK PHARMS","Labeling","Approval"
"02/04/2022","EPINEPHRINENDA   #205029","SUPPL-9","EPINEPHRINE","BPI LABS","Manufacturing (CMC)","Approval"
"02/04/2022","QUDEXY XRNDA   #205122","SUPPL-12","TOPIRAMATE","UPSHER SMITH LABS","Labeling","Approval"
"02/04/2022","PRASUGRELANDA  #205913","SUPPL-8","PRASUGREL HYDROCHLORIDE","AMNEAL PHARMS","Labeling","Approval"
"02/04/2022","VALTOCONDA   #211635","SUPPL-7","DIAZEPAM","NEURELIS INC","Labeling","Approval"
"02/04/2022","ARTESUNATENDA   #213036","SUPPL-1","ARTESUNATE","AMIVAS","Labeling","Approval"
"02/04/2022","DAPSONEANDA  #213847","ORIG-1","DAPSONE","MYLAN PHARMS","","Approval"
"02/04/2022","POSACONAZOLEANDA  #214476","ORIG-1","POSACONAZOLE","BIOCON PHARMA","","Approval"
"02/04/2022","FLEQSUVYNDA   #215602","ORIG-1","BACLOFEN","AZURITY","Type 3 - New Dosage Form","Approval"
"02/04/2022","TRUXIMABLA   #761088","SUPPL-18","RITUXIMAB-ABBS","CELLTRION INC","","Approval"
"02/04/2022","ENJAYMOBLA   #761164","ORIG-1","SUTIMLIMAB-JOME","BIOVERATIV THERAPEUTICS INC","","Approval"
"02/07/2022","BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDEANDA  #075768","SUPPL-20","BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE","MYLAN","Labeling","Approval"
"02/07/2022","BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDEANDA  #075768","SUPPL-22","BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE","MYLAN","Labeling","Approval"
"02/07/2022","NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATEANDA  #078267","SUPPL-14","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","AMNEAL PHARMS","Labeling","Approval"
"02/07/2022","MARAVIROCANDA  #203347","ORIG-1","MARAVIROC","HETERO LABS LTD III","","Approval"
"02/07/2022","HAILEY 24 FEANDA  #204847","SUPPL-3","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","GLENMARK PHARMS LTD","Labeling","Approval"
"02/07/2022","DAPTOMYCINNDA   #208385","SUPPL-7","DAPTOMYCIN","SAGENT PHARMS INC","Labeling","Approval"
"02/07/2022","DAPTOMYCINNDA   #208385","SUPPL-8","DAPTOMYCIN","SAGENT PHARMS INC","Labeling","Approval"
"02/07/2022","VOCABRIANDA   #212887","SUPPL-2","CABOTEGRAVIR SODIUM","VIIV HLTHCARE","Efficacy","Approval"
"02/07/2022","CABENUVA KITNDA   #212888","SUPPL-2","CABOTEGRAVIR; RILPIVIRINE","VIIV HLTHCARE","Efficacy","Approval"
"02/07/2022","ARFORMOTEROL TARTRATEANDA  #213068","ORIG-1","ARFORMOTEROL TARTRATE","LUPIN","","Approval"
"02/07/2022","SEVELAMER CARBONATEANDA  #215537","ORIG-1","SEVELAMER CARBONATE","MICRO LABS","","Approval"
"02/07/2022","MORPHINE SULFATEANDA  #215584","ORIG-1","MORPHINE SULFATE","INGENUS PHARMS NJ","","Approval"
"02/07/2022","SUCCINYLCHOLINE CHLORIDEANDA  #216003","ORIG-1","SUCCINYLCHOLINE CHLORIDE","BE PHARMS","","Approval"
"02/08/2022","PIROXICAMANDA  #074131","SUPPL-28","PIROXICAM","TEVA","Labeling","Approval"
"02/08/2022","ADVILNDA   #201803","SUPPL-16","IBUPROFEN SODIUM","GLAXOSMITHKLINE","Labeling","Approval"
"02/08/2022","CYCLAFEM 0.5/35ANDA  #203413","SUPPL-1","ETHINYL ESTRADIOL; NORETHINDRONE","VINTAGE PHARMS","Labeling","Approval"
"02/08/2022","NITROFURANTOINANDA  #205005","SUPPL-1","NITROFURANTOIN, MACROCRYSTALLINE","ZYDUS PHARMS","Labeling","Approval"
"02/08/2022","NITROFURANTOINANDA  #205005","SUPPL-3","NITROFURANTOIN, MACROCRYSTALLINE","ZYDUS PHARMS","Labeling","Approval"
"02/08/2022","ALEVE PMNDA   #205352","SUPPL-16","DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM","BAYER HLTHCARE","Labeling","Approval"
"02/08/2022","LUBIPROSTONEANDA  #206994","ORIG-1","LUBIPROSTONE","DR REDDYS","","Approval"
"02/08/2022","OXALIPLATINANDA  #207474","SUPPL-2","OXALIPLATIN","ACCORD HLTHCARE","Labeling","Approval"
"02/08/2022","ERTAPENEM SODIUMANDA  #207647","SUPPL-10","ERTAPENEM SODIUM","SAVIOR LIFETEC CORP","Labeling","Approval"
"02/08/2022","PHEXXINDA   #208352","SUPPL-2","CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE","EVOFEM INC","Labeling","Approval"
"02/08/2022","ROSUVASTATIN CALCIUMANDA  #212059","SUPPL-1","ROSUVASTATIN CALCIUM","ZHEJIANG YONGTAI","Labeling","Approval"
"02/08/2022","NALMEFENE HYDROCHLORIDEANDA  #212955","ORIG-1","NALMEFENE HYDROCHLORIDE","PURDUE PHARMA LP","","Approval"
"02/08/2022","SULFAMETHOXAZOLE AND TRIMETHOPRIMANDA  #214330","ORIG-1","SULFAMETHOXAZOLE; TRIMETHOPRIM","NOVITIUM PHARMA","","Approval"
"02/08/2022","SILDENAFIL CITRATEANDA  #214641","ORIG-1","SILDENAFIL CITRATE","MSN","","Approval"
"02/08/2022","DIGOXINANDA  #214982","ORIG-1","DIGOXIN","AUROBINDO PHARMA LTD","","Approval"
"02/08/2022","TAKHZYROBLA   #761090","SUPPL-3","LANDELUMAB-FLYO","DYAX CORP.","","Approval"
"02/09/2022","OCTREOSCANNDA   #020314","SUPPL-12","INDIUM IN-111 PENTETREOTIDE KIT","CURIUM","Labeling","Approval"
"02/09/2022","XYREMNDA   #021196","SUPPL-39","SODIUM OXYBATE","JAZZ PHARMS","REMS","Approval"
"02/09/2022","SUCCINYLCHOLINE CHLORIDEANDA  #209467","SUPPL-7","SUCCINYLCHOLINE CHLORIDE","ZYDUS PHARMS","Labeling","Approval"
"02/09/2022","CHLORTHALIDONEANDA  #211320","ORIG-1","CHLORTHALIDONE","INVENTIA","","Approval"
"02/09/2022","XYWAVNDA   #212690","SUPPL-9","CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE","JAZZ","REMS","Approval"
"02/09/2022","DOXEPIN HYDROCHLORIDEANDA  #215710","ORIG-1","DOXEPIN HYDROCHLORIDE","MANKIND PHARMA","","Approval"
"02/10/2022","NORTREL 1/35-21ANDA  #072693","SUPPL-26","ETHINYL ESTRADIOL; NORETHINDRONE","BARR","Labeling","Approval"
"02/10/2022","NORTREL 1/35-21ANDA  #072693","SUPPL-27","ETHINYL ESTRADIOL; NORETHINDRONE","BARR","Labeling","Approval"
"02/10/2022","NORTREL 1/35-21ANDA  #072693","SUPPL-28","ETHINYL ESTRADIOL; NORETHINDRONE","BARR","Labeling","Approval"
"02/10/2022","NORTREL 0.5/35-28ANDA  #072695","SUPPL-24","ETHINYL ESTRADIOL; NORETHINDRONE","BARR","Labeling","Approval"
"02/10/2022","NORTREL 0.5/35-28ANDA  #072695","SUPPL-25","ETHINYL ESTRADIOL; NORETHINDRONE","BARR","Labeling","Approval"
"02/10/2022","NORTREL 0.5/35-28ANDA  #072695","SUPPL-26","ETHINYL ESTRADIOL; NORETHINDRONE","BARR","Labeling","Approval"
"02/10/2022","NORTREL 1/35-28ANDA  #072696","SUPPL-25","ETHINYL ESTRADIOL; NORETHINDRONE","BARR","Labeling","Approval"
"02/10/2022","NORTREL 1/35-28ANDA  #072696","SUPPL-27","ETHINYL ESTRADIOL; NORETHINDRONE","BARR","Labeling","Approval"
"02/10/2022","NORTREL 1/35-28ANDA  #072696","SUPPL-28","ETHINYL ESTRADIOL; NORETHINDRONE","BARR","Labeling","Approval"
"02/10/2022","QUINIDINE SULFATEANDA  #088072","SUPPL-18","QUINIDINE SULFATE","EPIC PHARMA","Manufacturing (CMC)","Approval"
"02/10/2022","NPLATEBLA   #125268","SUPPL-172","ROMIPLOSTIM","AMGEN","","Approval"
"02/10/2022","TECFIDERANDA   #204063","SUPPL-27","DIMETHYL FUMARATE","BIOGEN INC","Labeling","Approval"
"02/10/2022","CYONANZANDA  #207055","SUPPL-1","ETHINYL ESTRADIOL; NORETHINDRONE","AUROBINDO PHARMA","Labeling","Approval"
"02/10/2022","NYLIA 1/35ANDA  #207056","SUPPL-1","ETHINYL ESTRADIOL; NORETHINDRONE","AUROBINDO PHARMA","Labeling","Approval"
"02/10/2022","ROFLUMILASTANDA  #208303","ORIG-1","ROFLUMILAST","ZYDUS PHARMS","","Approval"
"02/10/2022","AMPHETAMINE SULFATEANDA  #211139","SUPPL-4","AMPHETAMINE SULFATE","AMNEAL PHARMS","Labeling","Approval"
"02/10/2022","VUMERITYNDA   #211855","SUPPL-6","DIROXIMEL FUMARATE","BIOGEN INC","Labeling","Approval"
"02/10/2022","AMPHETAMINE SULFATEANDA  #212619","SUPPL-2","AMPHETAMINE SULFATE","GRANULES","Labeling","Approval"
"02/10/2022","CLINDAMYCIN PHOSPHATE AND TRETINOINANDA  #212845","ORIG-1","CLINDAMYCIN PHOSPHATE; TRETINOIN","SOLARIS PHARMA CORP","","Approval"
"02/10/2022","FULVESTRANTANDA  #214682","ORIG-1","FULVESTRANT","JIANGSU HANSOH PHARM","","Approval"
"02/10/2022","DAPSONEANDA  #214722","ORIG-1","DAPSONE","TORRENT","","Approval"
"02/10/2022","ESOMEPRAZOLE SODIUMANDA  #215732","ORIG-1","ESOMEPRAZOLE SODIUM","HAINAN POLY","","Approval"
"02/11/2022","HIBICLENSNDA   #017768","SUPPL-56","CHLORHEXIDINE GLUCONATE","MOLNLYCKE HLTH","Labeling","Approval"
"02/11/2022","ESBRIETNDA   #022535","SUPPL-15","PIRFENIDONE","GENENTECH INC","Labeling","Approval"
"02/11/2022","PROCYSBINDA   #203389","SUPPL-27","CYSTEAMINE BITARTRATE","HORIZON","Labeling","Approval"
"02/11/2022","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #206340","SUPPL-5","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","ACTAVIS ELIZABETH","Labeling","Approval"
"02/11/2022","ESBRIETNDA   #208780","SUPPL-5","PIRFENIDONE","GENENTECH INC","Labeling","Approval"
"02/11/2022","BRAFTOVINDA   #210496","SUPPL-13","ENCORAFENIB","ARRAY BIOPHARMA INC","Labeling","Approval"
"02/11/2022","CLOBAZAMANDA  #210746","SUPPL-1","CLOBAZAM","VISTAPHARM","Labeling","Approval"
"02/11/2022","CLOBAZAMANDA  #211259","SUPPL-2","CLOBAZAM","MYLAN PHARMS","Labeling","Approval"
"02/11/2022","TOBRAMYCIN AND DEXAMETHASONEANDA  #212715","ORIG-1","DEXAMETHASONE; TOBRAMYCIN","PADAGIS US","","Approval"
"02/11/2022","PROCYSBINDA   #213491","SUPPL-2","CYSTEAMINE BITARTRATE","HORIZON","Labeling","Approval"
"02/11/2022","PRAXBINDBLA   #761025","SUPPL-13","IDARUCIZUMAB","BOEHRINGER INGELHEIM","","Approval"
"02/14/2022","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #040422","SUPPL-56","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","BARR","Labeling","Approval"
"02/14/2022","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #040480","SUPPL-25","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","SUN PHARM INDUSTRIES","Labeling","Approval"
"02/14/2022","GAZYVABLA   #125486","SUPPL-29","OBINUTUZUMAB","GENENTECH","","Approval"
"02/14/2022","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #202424","SUPPL-5","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","AUROLIFE PHARMA LLC","Labeling","Approval"
"02/14/2022","VALSARTAN AND HYDROCHLOROTHIAZIDEANDA  #203145","SUPPL-26","HYDROCHLOROTHIAZIDE; VALSARTAN","MACLEODS PHARMS LTD","Labeling","Approval"
"02/14/2022","PRASUGRELANDA  #205888","SUPPL-6","PRASUGREL HYDROCHLORIDE","AUROBINDO PHARMA","Labeling","Approval"
"02/14/2022","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #206721","SUPPL-1","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","MYLAN","Labeling","Approval"
"02/14/2022","ERYTHROMYCIN LACTOBIONATEANDA  #215290","ORIG-1","ERYTHROMYCIN LACTOBIONATE","NEXUS PHARMS","","Approval"
"02/15/2022","ANCOBONNDA   #017001","SUPPL-34","FLUCYTOSINE","BAUSCH","Labeling","Approval"
"02/15/2022","GENTAMICIN SULFATEANDA  #062251","SUPPL-30","GENTAMICIN SULFATE","HIKMA","Labeling","Approval"
"02/15/2022","TRI-LO-ESTARYLLAANDA  #091232","SUPPL-1","ETHINYL ESTRADIOL; NORGESTIMATE","XIROMED","Labeling","Approval"
"02/15/2022","TRI-LO-ESTARYLLAANDA  #091232","SUPPL-2","ETHINYL ESTRADIOL; NORGESTIMATE","XIROMED","Labeling","Approval"
"02/15/2022","HEPARIN SODIUM PRESERVATIVE FREEANDA  #202732","SUPPL-13","HEPARIN SODIUM","SHENZHEN TECHDOW","Labeling","Approval"
"02/15/2022","HEPARIN SODIUM PRESERVATIVE FREEANDA  #202732","SUPPL-14","HEPARIN SODIUM","SHENZHEN TECHDOW","Labeling","Approval"
"02/15/2022","HEPARIN SODIUMANDA  #202733","SUPPL-11","HEPARIN SODIUM","SHENZHEN TECHDOW","Labeling","Approval"
"02/15/2022","HEPARIN SODIUMANDA  #202733","SUPPL-13","HEPARIN SODIUM","SHENZHEN TECHDOW","Labeling","Approval"
"02/15/2022","HEPARIN SODIUMANDA  #202957","SUPPL-13","HEPARIN SODIUM","SHENZHEN TECHDOW","Labeling","Approval"
"02/15/2022","HEPARIN SODIUMANDA  #202957","SUPPL-16","HEPARIN SODIUM","SHENZHEN TECHDOW","Labeling","Approval"
"02/15/2022","HEPARIN SODIUMANDA  #203198","SUPPL-12","HEPARIN SODIUM","SHENZHEN TECHDOW","Labeling","Approval"
"02/15/2022","HEPARIN SODIUMANDA  #203198","SUPPL-13","HEPARIN SODIUM","SHENZHEN TECHDOW","Labeling","Approval"
"02/15/2022","ICLUSIGNDA   #203469","SUPPL-35","PONATINIB HYDROCHLORIDE","TAKEDA PHARMS USA","Efficacy","Approval"
"02/15/2022","DEXTROAMPHETAMINE SULFATEANDA  #204330","SUPPL-1","DEXTROAMPHETAMINE SULFATE","NOVEL LABS INC","Labeling","Approval"
"02/15/2022","PIPERACILLIN AND TAZOBACTAMANDA  #204959","SUPPL-6","PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","QILU","Labeling","Approval"
"02/15/2022","TOLVAPTANANDA  #206119","ORIG-1","TOLVAPTAN","PAR PHARM INC","","Approval"
"02/15/2022","VANCOMYCIN HYDROCHLORIDEANDA  #213059","ORIG-1","VANCOMYCIN HYDROCHLORIDE","KNACK","","Approval"
"02/16/2022","DELESTROGENNDA   #009402","SUPPL-60","ESTRADIOL VALERATE","PAR STERILE PRODUCTS","Labeling","Approval"
"02/16/2022","ETHOSUXIMIDEANDA  #040430","SUPPL-19","ETHOSUXIMIDE","BIONPHARMA INC","Labeling","Approval"
"02/16/2022","LEVONESTANDA  #090719","SUPPL-5","ETHINYL ESTRADIOL; LEVONORGESTREL","NOVAST LABS LTD","Labeling","Approval"
"02/16/2022","FERROUS FUMARATEANDA  #090938","SUPPL-2","FERROUS FUMARATE","BARR LABS INC","Labeling","Approval"
"02/16/2022","FERROUS FUMARATEANDA  #090938","SUPPL-3","FERROUS FUMARATE","BARR LABS INC","Labeling","Approval"
"02/16/2022","FERROUS FUMARATEANDA  #090938","SUPPL-11","FERROUS FUMARATE","BARR LABS INC","Labeling","Approval"
"02/16/2022","NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATEANDA  #090938","SUPPL-2","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","BARR LABS INC","Labeling","Approval"
"02/16/2022","NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATEANDA  #090938","SUPPL-3","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","BARR LABS INC","Labeling","Approval"
"02/16/2022","NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATEANDA  #090938","SUPPL-11","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","BARR LABS INC","Labeling","Approval"
"02/16/2022","DASETTA 1/35ANDA  #090948","SUPPL-3","ETHINYL ESTRADIOL; NORETHINDRONE","NOVAST LABS LTD","Labeling","Approval"
"02/16/2022","DASETTA 1/35ANDA  #090948","SUPPL-5","ETHINYL ESTRADIOL; NORETHINDRONE","NOVAST LABS LTD","Labeling","Approval"
"02/16/2022","MARLISSAANDA  #091452","SUPPL-6","ETHINYL ESTRADIOL; LEVONORGESTREL","GLENMARK GENERICS","Labeling","Approval"
"02/16/2022","MARLISSAANDA  #091452","SUPPL-7","ETHINYL ESTRADIOL; LEVONORGESTREL","GLENMARK GENERICS","Labeling","Approval"
"02/16/2022","MARLISSAANDA  #091452","SUPPL-8","ETHINYL ESTRADIOL; LEVONORGESTREL","GLENMARK GENERICS","Labeling","Approval"
"02/16/2022","PRASUGRELANDA  #205790","SUPPL-3","PRASUGREL HYDROCHLORIDE","CHARTWELL RX","Labeling","Approval"
"02/16/2022","FIRVANQ KITNDA   #208910","SUPPL-5","VANCOMYCIN HYDROCHLORIDE","AZURITY","Labeling","Approval"
"02/16/2022","MORPHINE SULFATEANDA  #211454","SUPPL-1","MORPHINE SULFATE","WINDER LABS LLC","Labeling","Approval"
"02/16/2022","ACCRUFERNDA   #212320","SUPPL-11","FERRIC MALTOL","SHIELD TX","Labeling","Approval"
"02/16/2022","TROSPIUM CHLORIDEANDA  #215781","ORIG-1","TROSPIUM CHLORIDE","ZAMEER PHARMS","","Approval"
"02/17/2022","QUELICINNDA   #008845","SUPPL-79","SUCCINYLCHOLINE CHLORIDE","HOSPIRA","Labeling","Approval"
"02/17/2022","QUELICIN PRESERVATIVE FREENDA   #008845","SUPPL-79","SUCCINYLCHOLINE CHLORIDE","HOSPIRA","Labeling","Approval"
"02/17/2022","ALOPRIMNDA   #020298","SUPPL-12","ALLOPURINOL SODIUM","MYLAN","Labeling","Approval"
"02/17/2022","MONODOXNDA   #050641","SUPPL-32","DOXYCYCLINE","CHARTWELL RX","Manufacturing (CMC)","Approval"
"02/17/2022","AVIANE-21ANDA  #075796","SUPPL-24","ETHINYL ESTRADIOL; LEVONORGESTREL","DURAMED PHARMS BARR","Labeling","Approval"
"02/17/2022","AVIANE-28ANDA  #075796","SUPPL-24","ETHINYL ESTRADIOL; LEVONORGESTREL","DURAMED PHARMS BARR","Labeling","Approval"
"02/17/2022","MECLIZINE HYDROCHLORIDEANDA  #200432","ORIG-1","MECLIZINE HYDROCHLORIDE","INVAGEN PHARMS","","Approval"
"02/17/2022","MECLIZINE HYDROCHLORIDEANDA  #200791","ORIG-1","MECLIZINE HYDROCHLORIDE","INVAGEN PHARMS","","Approval"
"02/17/2022","LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERNDA   #206473","SUPPL-7","LINEZOLID","HOSPIRA","Labeling","Approval"
"02/17/2022","CRESEMBANDA   #207500","SUPPL-11","ISAVUCONAZONIUM SULFATE","ASTELLAS","Labeling","Approval"
"02/17/2022","CRESEMBANDA   #207501","SUPPL-9","ISAVUCONAZONIUM SULFATE","ASTELLAS","Labeling","Approval"
"02/17/2022","EGATENNDA   #208711","SUPPL-2","TRICLABENDAZOLE","NOVARTIS","Labeling","Approval"
"02/17/2022","VALGANCICLOVIR HYDROCHLORIDEANDA  #210169","ORIG-1","VALGANCICLOVIR HYDROCHLORIDE","MSN","","Approval"
"02/17/2022","CLOBETASOL PROPIONATEANDA  #211240","ORIG-1","CLOBETASOL PROPIONATE","QUAGEN","","Approval"
"02/17/2022","PYRUKYNDNDA   #216196","ORIG-1","MITAPIVAT SULFATE","AGIOS PHARMS INC","Type 1 - New Molecular Entity","Approval"
"02/18/2022","CONRAYNDA   #013295","SUPPL-72","IOTHALAMATE MEGLUMINE","LIEBEL-FLARSHEIM","Labeling","Approval"
"02/18/2022","CONRAY 43NDA   #013295","SUPPL-72","IOTHALAMATE MEGLUMINE","LIEBEL-FLARSHEIM","Labeling","Approval"
"02/18/2022","ISOVUE-128NDA   #018735","SUPPL-67","IOPAMIDOL","BRACCO","Labeling","Approval"
"02/18/2022","ISOVUE-200NDA   #018735","SUPPL-67","IOPAMIDOL","BRACCO","Labeling","Approval"
"02/18/2022","ISOVUE-250NDA   #018735","SUPPL-67","IOPAMIDOL","BRACCO","Labeling","Approval"
"02/18/2022","ISOVUE-300NDA   #018735","SUPPL-67","IOPAMIDOL","BRACCO","Labeling","Approval"
"02/18/2022","ISOVUE-370NDA   #018735","SUPPL-67","IOPAMIDOL","BRACCO","Labeling","Approval"
"02/18/2022","ISOVUE-M 200NDA   #018735","SUPPL-67","IOPAMIDOL","BRACCO","Labeling","Approval"
"02/18/2022","ISOVUE-M 300NDA   #018735","SUPPL-67","IOPAMIDOL","BRACCO","Labeling","Approval"
"02/18/2022","OMNIPAQUE 12NDA   #018956","SUPPL-113","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"02/18/2022","OMNIPAQUE 140NDA   #018956","SUPPL-113","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"02/18/2022","OMNIPAQUE 180NDA   #018956","SUPPL-113","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"02/18/2022","OMNIPAQUE 210NDA   #018956","SUPPL-113","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"02/18/2022","OMNIPAQUE 240NDA   #018956","SUPPL-113","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"02/18/2022","OMNIPAQUE 300NDA   #018956","SUPPL-113","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"02/18/2022","OMNIPAQUE 350NDA   #018956","SUPPL-113","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"02/18/2022","OMNIPAQUE 70NDA   #018956","SUPPL-113","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"02/18/2022","OMNIPAQUE 9NDA   #018956","SUPPL-113","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"02/18/2022","OPTIRAY 160NDA   #019710","SUPPL-65","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"02/18/2022","OPTIRAY 240NDA   #019710","SUPPL-65","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"02/18/2022","OPTIRAY 300NDA   #019710","SUPPL-65","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"02/18/2022","OPTIRAY 320NDA   #019710","SUPPL-65","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"02/18/2022","OPTIRAY 350NDA   #019710","SUPPL-65","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"02/18/2022","ULTRAVIST 150NDA   #020220","SUPPL-52","IOPROMIDE","BAYER HLTHCARE","Labeling","Approval"
"02/18/2022","ULTRAVIST 240NDA   #020220","SUPPL-52","IOPROMIDE","BAYER HLTHCARE","Labeling","Approval"
"02/18/2022","ULTRAVIST 300NDA   #020220","SUPPL-52","IOPROMIDE","BAYER HLTHCARE","Labeling","Approval"
"02/18/2022","ULTRAVIST 300 IN PLASTIC CONTAINERNDA   #020220","SUPPL-52","IOPROMIDE","BAYER HLTHCARE","Labeling","Approval"
"02/18/2022","ULTRAVIST 370NDA   #020220","SUPPL-52","IOPROMIDE","BAYER HLTHCARE","Labeling","Approval"
"02/18/2022","PEPCID ACNDA   #020325","SUPPL-37","FAMOTIDINE","J AND J CONSUMER INC","Manufacturing (CMC)","Approval"
"02/18/2022","ISOVUE-200NDA   #020327","SUPPL-23","IOPAMIDOL","BRACCO","Labeling","Approval"
"02/18/2022","ISOVUE-250NDA   #020327","SUPPL-23","IOPAMIDOL","BRACCO","Labeling","Approval"
"02/18/2022","ISOVUE-300NDA   #020327","SUPPL-23","IOPAMIDOL","BRACCO","Labeling","Approval"
"02/18/2022","ISOVUE-370NDA   #020327","SUPPL-23","IOPAMIDOL","BRACCO","Labeling","Approval"
"02/18/2022","VISIPAQUE 270NDA   #020351","SUPPL-54","IODIXANOL","GE HEALTHCARE","Labeling","Approval"
"02/18/2022","VISIPAQUE 320NDA   #020351","SUPPL-54","IODIXANOL","GE HEALTHCARE","Labeling","Approval"
"02/18/2022","OMNIPAQUE 240NDA   #020608","SUPPL-45","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"02/18/2022","OMNIPAQUE 300NDA   #020608","SUPPL-45","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"02/18/2022","OMNIPAQUE 350NDA   #020608","SUPPL-45","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"02/18/2022","VISIPAQUE 270NDA   #020808","SUPPL-32","IODIXANOL","GE HEALTHCARE","Labeling","Approval"
"02/18/2022","VISIPAQUE 320NDA   #020808","SUPPL-32","IODIXANOL","GE HEALTHCARE","Labeling","Approval"
"02/18/2022","OPTIRAY 240NDA   #020923","SUPPL-28","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"02/18/2022","OPTIRAY 300NDA   #020923","SUPPL-28","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"02/18/2022","OPTIRAY 320NDA   #020923","SUPPL-28","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"02/18/2022","OPTIRAY 350NDA   #020923","SUPPL-28","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"02/18/2022","ULTRAVIST (PHARMACY BULK)NDA   #021425","SUPPL-34","IOPROMIDE","BAYER HLTHCARE","Labeling","Approval"
"02/18/2022","BLINCYTOBLA   #125557","SUPPL-21","BLINATUMOMAB","AMGEN","","Approval"
"02/18/2022","ZYDELIGNDA   #205858","SUPPL-16","IDELALISIB","GILEAD SCIENCES INC","Labeling","Approval"
"02/18/2022","DARIFENACIN HYDROBROMIDEANDA  #207664","SUPPL-4","DARIFENACIN HYDROBROMIDE","CIPLA","Labeling","Approval"
"02/18/2022","NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)ANDA  #211013","ORIG-1","NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE","INVENTIA","","Approval"
"02/18/2022","AMANTADINE HYDROCHLORIDEANDA  #211354","ORIG-1","AMANTADINE HYDROCHLORIDE","STRIDES PHARMA","","Approval"
"02/18/2022","PREGABALINANDA  #212604","ORIG-1","PREGABALIN","PATRIN","","Approval"
"02/18/2022","CARDIOPLEGIC IN PLASTIC CONTAINERANDA  #214623","ORIG-1","CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","FRESENIUS KABI USA","","Approval"
"02/18/2022","NEPHROSCANNDA   #214993","ORIG-1","TECHNETIUM TC-99M SUCCIMER","THERAGNOSTICS","Type 5 - New Formulation or New Manufacturer","Approval"
"02/18/2022","BETAMETHASONE DIPROPIONATEANDA  #215186","ORIG-1","BETAMETHASONE DIPROPIONATE","TASMAN PHARMA","","Approval"
"02/18/2022","METHYLTESTOSTERONEANDA  #215270","ORIG-1","METHYLTESTOSTERONE","NOVITIUM PHARMA","","Approval"
"02/18/2022","BEOVUBLA   #761125","SUPPL-10","brolucizumab-dbll","NOVARTIS PHARMS CORP","","Approval"
"02/18/2022","BEOVUBLA   #761125","SUPPL-12","brolucizumab-dbll","NOVARTIS PHARMS CORP","","Approval"
"02/18/2022","BEOVUBLA   #761125","SUPPL-13","brolucizumab-dbll","NOVARTIS PHARMS CORP","","Approval"
"02/22/2022","TRIVORA-21ANDA  #074538","SUPPL-27","ETHINYL ESTRADIOL; LEVONORGESTREL","DR REDDYS LABS SA","Labeling","Approval"
"02/22/2022","TRIVORA-28ANDA  #074538","SUPPL-27","ETHINYL ESTRADIOL; LEVONORGESTREL","DR REDDYS LABS SA","Labeling","Approval"
"02/22/2022","ETHOSUXIMIDEANDA  #200892","SUPPL-14","ETHOSUXIMIDE","HERITAGE PHARMS INC","Labeling","Approval"
"02/22/2022","LERIBANEANDA  #203435","SUPPL-1","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","NOVAST LABS","Labeling","Approval"
"02/22/2022","IBANDRONATE SODIUMANDA  #204502","SUPPL-2","IBANDRONATE SODIUM","AUROBINDO PHARMA","Labeling","Approval"
"02/22/2022","TETRACAINE HYDROCHLORIDENDA   #210821","SUPPL-5","TETRACAINE HYDROCHLORIDE","BAUSCH LOMB IRELAND","Labeling","Approval"
"02/22/2022","DAPAGLIFLOZINANDA  #211582","ORIG-1","DAPAGLIFLOZIN","ZYDUS PHARMS","","Approval"
"02/22/2022","METFORMIN HYDROCHLORIDEANDA  #214629","ORIG-1","METFORMIN HYDROCHLORIDE","SCIEGEN PHARMS INC","","Approval"
"02/23/2022","AMBIENNDA   #019908","SUPPL-40","ZOLPIDEM TARTRATE","SANOFI AVENTIS US","Labeling","Approval"
"02/23/2022","AMBIENNDA   #019908","SUPPL-44","ZOLPIDEM TARTRATE","SANOFI AVENTIS US","Labeling","Approval"
"02/23/2022","AMBIENNDA   #019908","SUPPL-47","ZOLPIDEM TARTRATE","SANOFI AVENTIS US","Labeling","Approval"
"02/23/2022","CUBICINNDA   #021572","SUPPL-68","DAPTOMYCIN","CUBIST PHARMS LLC","Labeling","Approval"
"02/23/2022","CUBICIN RFNDA   #021572","SUPPL-68","DAPTOMYCIN","CUBIST PHARMS LLC","Labeling","Approval"
"02/23/2022","AMBIEN CRNDA   #021774","SUPPL-21","ZOLPIDEM TARTRATE","SANOFI AVENTIS US","Labeling","Approval"
"02/23/2022","AMBIEN CRNDA   #021774","SUPPL-25","ZOLPIDEM TARTRATE","SANOFI AVENTIS US","Labeling","Approval"
"02/23/2022","AMBIEN CRNDA   #021774","SUPPL-28","ZOLPIDEM TARTRATE","SANOFI AVENTIS US","Labeling","Approval"
"02/23/2022","NORGESTIMATE AND ETHINYL ESTRADIOLANDA  #076626","SUPPL-1","ETHINYL ESTRADIOL; NORGESTIMATE","WATSON LABS","Labeling","Approval"
"02/23/2022","NORGESTIMATE AND ETHINYL ESTRADIOLANDA  #076627","SUPPL-1","ETHINYL ESTRADIOL; NORGESTIMATE","WATSON LABS","Labeling","Approval"
"02/23/2022","LINEZOLIDANDA  #205517","SUPPL-4","LINEZOLID","ALKEM LABS LTD","Labeling","Approval"
"02/23/2022","BROMFENACANDA  #207334","ORIG-1","BROMFENAC","APOTEX INC","","Tentative Approval"
"02/23/2022","BONJESTANDA   #209661","SUPPL-7","DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE","DUCHESNAY","Manufacturing (CMC)","Approval"
"02/23/2022","ALIQOPANDA   #209936","SUPPL-10","COPANLISIB DIHYDROCHLORIDE","BAYER HEALTHCARE","Labeling","Approval"
"02/23/2022","APOMORPHINE HYDROCHLORIDEANDA  #212025","ORIG-1","APOMORPHINE HYDROCHLORIDE","SAGE CHEMS","","Approval"
"02/23/2022","SUCCINYLCHOLINE CHLORIDEANDA  #214246","SUPPL-2","SUCCINYLCHOLINE CHLORIDE","GLAND PHARMA LTD","Labeling","Approval"
"02/23/2022","DEFERASIROXANDA  #215026","ORIG-1","DEFERASIROX","CIPLA","","Approval"
"02/23/2022","ACETYLCYSTEINEANDA  #215620","ORIG-1","ACETYLCYSTEINE","INDOCO","","Approval"
"02/23/2022","MIDOSTAURINANDA  #216076","ORIG-1","MIDOSTAURIN","TEVA PHARMS","","Tentative Approval"
"02/23/2022","TRIAMTERENE AND HYDROCHLOROTHIAZIDEANDA  #216211","ORIG-1","HYDROCHLOROTHIAZIDE; TRIAMTERENE","RUBICON","","Approval"
"02/23/2022","CABLIVIBLA   #761112","SUPPL-9","CAPLACIZUMAB-YHDP","ABLYNX NV","","Approval"
"02/24/2022","NORETHINDRONE AND ETHINYL ESTRADIOLANDA  #070687","SUPPL-43","ETHINYL ESTRADIOL; NORETHINDRONE","WATSON LABS TEVA","Labeling","Approval"
"02/24/2022","NORETHIN 1/35E-28ANDA  #071481","SUPPL-15","ETHINYL ESTRADIOL; NORETHINDRONE","WATSON LABS","Labeling","Approval"
"02/24/2022","CEFAZOLIN SODIUMANDA  #203661","SUPPL-6","CEFAZOLIN SODIUM","QILU","Labeling","Approval"
"02/24/2022","JARDIANCENDA   #204629","SUPPL-33","EMPAGLIFLOZIN","BOEHRINGER INGELHEIM","Efficacy","Approval"
"02/24/2022","ATORVASTATIN CALCIUMANDA  #206536","SUPPL-7","ATORVASTATIN CALCIUM","ZYDUS PHARMS","Labeling","Approval"
"02/24/2022","ATORVASTATIN CALCIUMANDA  #206536","SUPPL-8","ATORVASTATIN CALCIUM","ZYDUS PHARMS","Labeling","Approval"
"02/24/2022","ATORVASTATIN CALCIUMANDA  #206536","SUPPL-10","ATORVASTATIN CALCIUM","ZYDUS PHARMS","Labeling","Approval"
"02/24/2022","ATORVASTATIN CALCIUMANDA  #206536","SUPPL-11","ATORVASTATIN CALCIUM","ZYDUS PHARMS","Labeling","Approval"
"02/24/2022","OCALIVANDA   #207999","SUPPL-8","OBETICHOLIC ACID","INTERCEPT PHARMS INC","Labeling","Approval"
"02/24/2022","EPIDIOLEXNDA   #210365","SUPPL-15","CANNABIDIOL","GW RES LTD","Labeling","Approval"
"02/24/2022","CHLORTHALIDONEANDA  #212875","ORIG-1","CHLORTHALIDONE","TAGI","","Approval"
"02/24/2022","CHLORTHALIDONEANDA  #212878","ORIG-1","CHLORTHALIDONE","TAGI","","Approval"
"02/24/2022","NORLIQVANDA   #214439","ORIG-1","AMLODIPINE BESYLATE","CMP DEV LLC","Type 5 - New Formulation or New Manufacturer","Approval"
"02/24/2022","ENALAPRIL MALEATEANDA  #214467","ORIG-1","ENALAPRIL MALEATE","ANNORA PHARMA","","Approval"
"02/25/2022","DESOXYNNDA   #005378","SUPPL-37","METHAMPHETAMINE HYDROCHLORIDE","KEY THERAP","Labeling","Approval"
"02/25/2022","ADDERALL 10NDA   #011522","SUPPL-44","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","TEVA WOMENS","Labeling","Approval"
"02/25/2022","ADDERALL 12.5NDA   #011522","SUPPL-44","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","TEVA WOMENS","Labeling","Approval"
"02/25/2022","ADDERALL 15NDA   #011522","SUPPL-44","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","TEVA WOMENS","Labeling","Approval"
"02/25/2022","ADDERALL 20NDA   #011522","SUPPL-44","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","TEVA WOMENS","Labeling","Approval"
"02/25/2022","ADDERALL 30NDA   #011522","SUPPL-44","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","TEVA WOMENS","Labeling","Approval"
"02/25/2022","ADDERALL 5NDA   #011522","SUPPL-44","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","TEVA WOMENS","Labeling","Approval"
"02/25/2022","ADDERALL 7.5NDA   #011522","SUPPL-44","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","TEVA WOMENS","Labeling","Approval"
"02/25/2022","DEXEDRINENDA   #017078","SUPPL-54","DEXTROAMPHETAMINE SULFATE","IMPAX LABS INC","Labeling","Approval"
"02/25/2022","ADDERALL XR 10NDA   #021303","SUPPL-36","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","TAKEDA PHARMS USA","Labeling","Approval"
"02/25/2022","ADDERALL XR 15NDA   #021303","SUPPL-36","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","TAKEDA PHARMS USA","Labeling","Approval"
"02/25/2022","ADDERALL XR 20NDA   #021303","SUPPL-36","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","TAKEDA PHARMS USA","Labeling","Approval"
"02/25/2022","ADDERALL XR 25NDA   #021303","SUPPL-36","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","TAKEDA PHARMS USA","Labeling","Approval"
"02/25/2022","ADDERALL XR 30NDA   #021303","SUPPL-36","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","TAKEDA PHARMS USA","Labeling","Approval"
"02/25/2022","ADDERALL XR 5NDA   #021303","SUPPL-36","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","TAKEDA PHARMS USA","Labeling","Approval"
"02/25/2022","VYVANSENDA   #021977","SUPPL-48","LISDEXAMFETAMINE DIMESYLATE","TAKEDA PHARMS USA","Labeling","Approval"
"02/25/2022","MYDAYISNDA   #022063","SUPPL-3","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","TAKEDA PHARMS USA","Labeling","Approval"
"02/25/2022","ACUVUE THERAVISION WITH KETOTIFENNDA   #022388","ORIG-1","KETOTIFEN FUMARATE","JOHNSON JOHNSON VISN","Type 3 - New Dosage Form and Type 4 - New Combination","Approval"
"02/25/2022","ACUVUE THERAVISION WITH KETOTIFENNDA   #022388","SUPPL-1","KETOTIFEN FUMARATE","JOHNSON JOHNSON VISN","Type 3 - New Dosage Form","Approval"
"02/25/2022","METAXALONENDA   #022503","SUPPL-1","METAXALONE","PRIMUS PHARMS","Labeling","Approval"
"02/25/2022","DEXTROAMPHETAMINE SULFATEANDA  #040299","SUPPL-4","DEXTROAMPHETAMINE SULFATE","STRIDES PHARMA","Labeling","Approval"
"02/25/2022","DEXTROAMPHETAMINE SULFATEANDA  #040361","SUPPL-30","DEXTROAMPHETAMINE SULFATE","BARR","Labeling","Approval"
"02/25/2022","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #040422","SUPPL-57","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","BARR","Labeling","Approval"
"02/25/2022","DEXTROAMPHETAMINE SULFATEANDA  #040436","SUPPL-22","DEXTROAMPHETAMINE SULFATE","SPECGX LLC","Labeling","Approval"
"02/25/2022","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #040439","SUPPL-29","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","SANDOZ","Labeling","Approval"
"02/25/2022","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #040440","SUPPL-26","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","SPECGX LLC","Labeling","Approval"
"02/25/2022","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #040444","SUPPL-24","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","EPIC PHARMA LLC","Labeling","Approval"
"02/25/2022","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #040444","SUPPL-32","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","EPIC PHARMA LLC","Labeling","Approval"
"02/25/2022","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #040444","SUPPL-33","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","EPIC PHARMA LLC","Labeling","Approval"
"02/25/2022","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #040480","SUPPL-32","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","SUN PHARM INDUSTRIES","Labeling","Approval"
"02/25/2022","DEXTROAMPHETAMINE SULFATEANDA  #040776","SUPPL-6","DEXTROAMPHETAMINE SULFATE","PRASCO","Labeling","Approval"
"02/25/2022","TRIAMTERENE AND HYDROCHLOROTHIAZIDEANDA  #071851","SUPPL-37","HYDROCHLOROTHIAZIDE; TRIAMTERENE","WATSON LABS","Labeling","Approval"
"02/25/2022","TRIAMTERENE AND HYDROCHLOROTHIAZIDEANDA  #073449","SUPPL-25","HYDROCHLOROTHIAZIDE; TRIAMTERENE","WATSON LABS","Labeling","Approval"
"02/25/2022","NORETHINDRONE AND ETHINYL ESTRADIOLANDA  #076393","SUPPL-7","ETHINYL ESTRADIOL; NORETHINDRONE","WATSON LABS","Labeling","Approval"
"02/25/2022","PAROXETINE HYDROCHLORIDEANDA  #077584","SUPPL-34","PAROXETINE HYDROCHLORIDE","ZYDUS PHARMS USA","Labeling","Approval"
"02/25/2022","PAROXETINE HYDROCHLORIDEANDA  #077584","SUPPL-35","PAROXETINE HYDROCHLORIDE","ZYDUS PHARMS USA","Labeling","Approval"
"02/25/2022","AMPHETAMINE SULFATEANDA  #083901","SUPPL-6","AMPHETAMINE SULFATE","LANNETT","Labeling","Approval"
"02/25/2022","DEXTROAMPHETAMINE SULFATEANDA  #083903","SUPPL-29","DEXTROAMPHETAMINE SULFATE","LANNETT","Labeling","Approval"
"02/25/2022","DEXTROAMPHETAMINE SULFATEANDA  #085652","SUPPL-6","DEXTROAMPHETAMINE SULFATE","LANNETT","Labeling","Approval"
"02/25/2022","DEXTROAMPHETAMINE SULFATEANDA  #090533","SUPPL-11","DEXTROAMPHETAMINE SULFATE","ARBOR PHARMS LLC","Labeling","Approval"
"02/25/2022","DEXTROAMPHETAMINE SULFATEANDA  #090652","SUPPL-7","DEXTROAMPHETAMINE SULFATE","EPIC PHARMA LLC","Labeling","Approval"
"02/25/2022","YERVOYBLA   #125377","SUPPL-126","IPILIMUMAB","BRISTOL MYERS SQUIBB","","Approval"
"02/25/2022","YERVOYBLA   #125377","SUPPL-127","IPILIMUMAB","BRISTOL MYERS SQUIBB","","Approval"
"02/25/2022","OPDIVOBLA   #125554","SUPPL-109","NIVOLUMAB","BRISTOL MYERS SQUIBB","","Approval"
"02/25/2022","EVEKEOANDA  #200166","SUPPL-9","AMPHETAMINE SULFATE","ARBOR PHARMS LLC","Labeling","Approval"
"02/25/2022","CYSTARANNDA   #200740","SUPPL-3","CYSTEAMINE HYDROCHLORIDE","LEADIANT BIOSCI INC","Manufacturing (CMC)","Approval"
"02/25/2022","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #202424","SUPPL-7","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","AUROLIFE PHARMA LLC","Labeling","Approval"
"02/25/2022","DEXTROAMPHETAMINE SULFATEANDA  #202893","SUPPL-4","DEXTROAMPHETAMINE SULFATE","AUROLIFE PHARMA LLC","Labeling","Approval"
"02/25/2022","DEXTROAMPHETAMINE SULFATEANDA  #203548","SUPPL-6","DEXTROAMPHETAMINE SULFATE","AVANTHI INC","Labeling","Approval"
"02/25/2022","DEXTROAMPHETAMINE SULFATEANDA  #203644","SUPPL-9","DEXTROAMPHETAMINE SULFATE","TRIS PHARMA INC","Labeling","Approval"
"02/25/2022","ADZENYS ERNDA   #204325","SUPPL-3","AMPHETAMINE","NEOS THERAPS INC","Labeling","Approval"
"02/25/2022","ADZENYS XR-ODTNDA   #204326","SUPPL-8","AMPHETAMINE","NEOS THERAPS","Labeling","Approval"
"02/25/2022","DEXTROAMPHETAMINE SULFATEANDA  #204330","SUPPL-2","DEXTROAMPHETAMINE SULFATE","NOVEL LABS INC","Labeling","Approval"
"02/25/2022","NUVESSANDA   #205223","SUPPL-6","METRONIDAZOLE","CHEMO RESEARCH SL","Labeling","Approval"
"02/25/2022","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #206340","SUPPL-6","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","ACTAVIS ELIZABETH","Labeling","Approval"
"02/25/2022","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #206721","SUPPL-3","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","MYLAN","Labeling","Approval"
"02/25/2022","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #207340","SUPPL-3","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","ZYDUS PHARMS","Labeling","Approval"
"02/25/2022","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #207388","SUPPL-3","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","ALVOGEN","Labeling","Approval"
"02/25/2022","DYANAVEL XRNDA   #208147","SUPPL-13","AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE","TRIS PHARMA INC","Labeling","Approval"
"02/25/2022","VYVANSENDA   #208510","SUPPL-5","LISDEXAMFETAMINE DIMESYLATE","TAKEDA PHARMS USA","Labeling","Approval"
"02/25/2022","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #209799","SUPPL-2","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","NUVO PHARM","Labeling","Approval"
"02/25/2022","EVEKEO ODTNDA   #209905","SUPPL-2","AMPHETAMINE SULFATE","AZURITY","Labeling","Approval"
"02/25/2022","DEXTROAMPHETAMINE SULFATEANDA  #210059","SUPPL-2","DEXTROAMPHETAMINE SULFATE","NUVO PHARM","Labeling","Approval"
"02/25/2022","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #210293","SUPPL-1","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","USPHARMA WINDLAS","Labeling","Approval"
"02/25/2022","DYANAVEL XR 10NDA   #210526","SUPPL-3","AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE","TRIS PHARMA INC","Labeling","Approval"
"02/25/2022","DYANAVEL XR 15NDA   #210526","SUPPL-3","AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE","TRIS PHARMA INC","Labeling","Approval"
"02/25/2022","DYANAVEL XR 20NDA   #210526","SUPPL-3","AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE","TRIS PHARMA INC","Labeling","Approval"
"02/25/2022","DYANAVEL XR 5NDA   #210526","SUPPL-3","AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE","TRIS PHARMA INC","Labeling","Approval"
"02/25/2022","ARAKODANDA   #210607","SUPPL-2","TAFENOQUINE SUCCINATE","60 DEGREES PHARMS","Manufacturing (CMC)","Approval"
"02/25/2022","AMPHETAMINE SULFATEANDA  #211139","SUPPL-5","AMPHETAMINE SULFATE","AMNEAL PHARMS","Labeling","Approval"
"02/25/2022","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #211352","SUPPL-7","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","ELITE LABS INC","Labeling","Approval"
"02/25/2022","AMPHETAMINE SULFATEANDA  #211639","SUPPL-2","AMPHETAMINE SULFATE","AUROLIFE PHARMA LLC","Labeling","Approval"
"02/25/2022","AMPHETAMINE SULFATEANDA  #211861","SUPPL-1","AMPHETAMINE SULFATE","PRINSTON INC","Labeling","Approval"
"02/25/2022","DEXTROAMPHETAMINE SULFATEANDA  #212160","SUPPL-1","DEXTROAMPHETAMINE SULFATE","WINDER LABS LLC","Labeling","Approval"
"02/25/2022","AMPHETAMINE SULFATEANDA  #212186","SUPPL-1","AMPHETAMINE SULFATE","GLENMARK PHARMS LTD","Labeling","Approval"
"02/25/2022","AMPHETAMINE SULFATEANDA  #212582","SUPPL-1","AMPHETAMINE SULFATE","CEROVENE INC","Labeling","Approval"
"02/25/2022","AMPHETAMINE SULFATEANDA  #212619","SUPPL-4","AMPHETAMINE SULFATE","GRANULES","Labeling","Approval"
"02/25/2022","AMPHETAMINE SULFATEANDA  #212901","SUPPL-1","AMPHETAMINE SULFATE","RISE PHARMA","Labeling","Approval"
"02/25/2022","AMPHETAMINE SULFATEANDA  #212919","SUPPL-3","AMPHETAMINE SULFATE","BIONPHARMA INC","Labeling","Approval"
"02/25/2022","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #213111","SUPPL-1","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","RHODES PHARMS","Labeling","Approval"
"02/25/2022","AMPHETAMINE SULFATEANDA  #213583","SUPPL-2","AMPHETAMINE SULFATE","SPECGX LLC","Labeling","Approval"
"02/25/2022","DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #213709","SUPPL-1","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","ASCENT PHARMS INC","Labeling","Approval"
"02/25/2022","AMPHETAMINE SULFATEANDA  #213720","SUPPL-1","AMPHETAMINE SULFATE","ALKEM LABS LTD","Labeling","Approval"
"02/25/2022","AMPHETAMINE SULFATEANDA  #213763","SUPPL-1","AMPHETAMINE SULFATE","NOVAST LABS","Labeling","Approval"
"02/25/2022","AMPHETAMINE SULFATEANDA  #213852","SUPPL-1","AMPHETAMINE SULFATE","RHODES PHARMS","Labeling","Approval"
"02/25/2022","AMPHETAMINE SULFATEANDA  #213898","SUPPL-1","AMPHETAMINE SULFATE","DR REDDYS LABS SA","Labeling","Approval"
"02/25/2022","AMPHETAMINE SULFATEANDA  #213980","SUPPL-1","AMPHETAMINE SULFATE","EPIC PHARMA LLC","Labeling","Approval"
"02/25/2022","AMPHETAMINE SULFATEANDA  #214574","SUPPL-1","AMPHETAMINE SULFATE","SUN PHARM INDS INC","Labeling","Approval"
"02/25/2022","DIVALPROEX SODIUMANDA  #214643","ORIG-1","DIVALPROEX SODIUM","UNICHEM","","Approval"
"02/25/2022","EPHEDRINE SULFATEANDA  #216146","ORIG-1","EPHEDRINE SULFATE","GLAND PHARMA LTD","","Approval"
"02/25/2022","CARBON DIOXIDE, USPNDA   #217082","ORIG-1","CARBON DIOXIDE","CONTINENTAL CARBONIC PRODUCTS, INC.","","Approval"
"02/25/2022","RELEUKOBLA   #761082","ORIG-1","FILGRASTIM-AYOW","KASHIV BIOSCIENCES LLC","","Approval"
"02/28/2022","FLUOROPLEXNDA   #016988","SUPPL-33","FLUOROURACIL","CHARTWELL RX","Labeling","Approval"
"02/28/2022","AKTENNDA   #022221","SUPPL-8","LIDOCAINE HYDROCHLORIDE","THEA PHARMA","Labeling","Approval"
"02/28/2022","LOW-OGESTREL-21ANDA  #075288","SUPPL-23","ETHINYL ESTRADIOL; NORGESTREL","DR REDDYS LABS SA","Labeling","Approval"
"02/28/2022","LOW-OGESTREL-28ANDA  #075288","SUPPL-23","ETHINYL ESTRADIOL; NORGESTREL","DR REDDYS LABS SA","Labeling","Approval"
"02/28/2022","OMEPRAZOLEANDA  #076048","SUPPL-26","OMEPRAZOLE","APOTEX","Labeling","Approval"
"02/28/2022","WERAANDA  #091204","SUPPL-3","ETHINYL ESTRADIOL; NORETHINDRONE","NOVAST LABS LTD","Labeling","Approval"
"02/28/2022","WERAANDA  #091204","SUPPL-5","ETHINYL ESTRADIOL; NORETHINDRONE","NOVAST LABS LTD","Labeling","Approval"
"02/28/2022","IRBESARTAN AND HYDROCHLOROTHIAZIDEANDA  #091539","SUPPL-2","HYDROCHLOROTHIAZIDE; IRBESARTAN","WATSON LABS INC","Labeling","Approval"
"02/28/2022","ACTEMRABLA   #125276","SUPPL-134","TOCILIZUMAB","GENENTECH","","Approval"
"02/28/2022","MYALEPTBLA   #125390","SUPPL-24","METRELEPTIN","AEGERION","","Approval"
"02/28/2022","ACTEMRABLA   #125472","SUPPL-46","TOCILIZUMAB","GENENTECH","","Approval"
"02/28/2022","IRBESARTANANDA  #202910","SUPPL-15","IRBESARTAN","HETERO LABS LTD V","Labeling","Approval"
"02/28/2022","ONDANSETRON HYDROCHLORIDEANDA  #203711","SUPPL-13","ONDANSETRON HYDROCHLORIDE","QILU PHARM HAINAN","Labeling","Approval"
"02/28/2022","CELECOXIBANDA  #205129","SUPPL-1","CELECOXIB","SCIEGEN PHARMS INC","Labeling","Approval"
"02/28/2022","BORTEZOMIBNDA   #206927","SUPPL-2","BORTEZOMIB","DR REDDYS","Labeling","Approval"
"02/28/2022","TETRACAINE HYDROCHLORIDENDA   #208135","SUPPL-5","TETRACAINE HYDROCHLORIDE","ALCON LABS","Labeling","Approval"
"02/28/2022","CYTARABINEANDA  #208485","ORIG-1","CYTARABINE","MEITHEAL","","Approval"
"02/28/2022","VONJONDA   #208712","ORIG-1","PACRITINIB CITRATE","CTI BIOPHARMA CORP","Type 1 - New Molecular Entity","Approval"
"02/28/2022","ALUNBRIGNDA   #208772","SUPPL-13","BRIGATINIB","TAKEDA PHARMS USA","Efficacy","Approval"
"02/28/2022","DICLOFENAC SODIUMANDA  #209484","SUPPL-2","DICLOFENAC SODIUM","AKORN","Labeling","Approval"
"02/28/2022","OSELTAMIVIR PHOSPHATEANDA  #214949","ORIG-1","OSELTAMIVIR PHOSPHATE","LEADING","","Approval"
"02/28/2022","THIOTHIXENEANDA  #215456","ORIG-1","THIOTHIXENE","AMNEAL","","Approval"
"02/28/2022","NALOXONE HYDROCHLORIDE (AUTOINJECTOR)NDA   #215457","ORIG-1","NALOXONE HYDROCHLORIDE","KALEO INC","Type 5 - New Formulation or New Manufacturer","Approval"
"02/28/2022","ASPRUZYO SPRINKLENDA   #216018","ORIG-1","RANOLAZINE","SPIL","Type 3 - New Dosage Form","Approval"
"02/28/2022","BLENREPBLA   #761158","SUPPL-6","BELANTAMAB MAFODOTIN-BLMF","GLAXOSMITHKLINE","","Approval"